Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Asset Writedowns and Impairment (2020 - 2025)

Historic Asset Writedowns and Impairment for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to $286000.0.

  • Alignment Healthcare's Asset Writedowns and Impairment rose 92142.86% to $286000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $576000.0, marking a year-over-year increase of 36829.27%. This contributed to the annual value of $123000.0 for FY2024, which is 3516.48% up from last year.
  • As of Q3 2025, Alignment Healthcare's Asset Writedowns and Impairment stood at $286000.0, which was up 92142.86% from $262000.0 recorded in Q2 2025.
  • Alignment Healthcare's Asset Writedowns and Impairment's 5-year high stood at $286000.0 during Q3 2025, with a 5-year trough of $1000.0 in Q1 2023.
  • Its 5-year average for Asset Writedowns and Impairment is $73071.4, with a median of $39500.0 in 2022.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first plummeted by 9811.32% in 2023, then skyrocketed by 92142.86% in 2025.
  • Over the past 5 years, Alignment Healthcare's Asset Writedowns and Impairment (Quarter) stood at $37000.0 in 2021, then rose by 5.41% to $39000.0 in 2022, then rose by 2.56% to $40000.0 in 2023, then dropped by 30.0% to $28000.0 in 2024, then soared by 921.43% to $286000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $286000.0 for Q3 2025, versus $262000.0 for Q2 2025 and $28000.0 for Q3 2024.